2018\u5e747\u670824\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001Idorsia Pharmaceuticals\u793e(\u4ee5\u4e0b Idorsia\u793e)\u304c³Ô¹Ï±¬ÁÏ Development Cloud<\/a><\/strong>\u306b\u3088\u308b\u7d71\u5408\u3055\u308c\u305f\u958b\u767a\u74b0\u5883\u3092\u69cb\u7bc9\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u81e8\u5e8a\u958b\u767a\u30fb\u85ac\u4e8b\u30fb\u54c1\u8cea\u696d\u52d9\u306b\u304a\u3051\u308b\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5358\u4e00\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u7d71\u5408\u3059\u308b\u3053\u3068\u3067\u3001Idorsia\u793e\u306f\u88fd\u54c1\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3055\u305b\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u6210\u9577\u8a08\u753b\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u305f\u3081\u306e\u60c5\u5831\u6280\u8853\u57fa\u76e4\u3092\u78ba\u7acb\u3057\u307e\u3057\u305f\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n <\/p>\n Idorsia\u793e\u306eCIO\u3067\u3042\u308bJoseph Bejjani\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u9769\u65b0\u7684\u306a\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u306e\u5019\u88dc\u5316\u5408\u7269\u3092\u591a\u304f\u6301\u3064\u5f53\u793e\u306f\u3001\u4f1a\u793e\u306e\u6210\u9577\u306b\u5408\u308f\u305b\u3066\u62e1\u5f35\u3067\u304d\u308b\u6700\u5148\u7aef\u306e\u30af\u30e9\u30a6\u30c9\u6280\u8853\u3092\u5fc5\u8981\u3068\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u5f53\u793e\u306eIT\u6226\u7565\u3067\u306f\u3001\u88fd\u54c1\u9078\u5b9a\u306b\u304a\u3044\u3066\u3001\u30af\u30e9\u30a6\u30c9\u30d5\u30a1\u30fc\u30b9\u30c8\u3001\u6a5f\u80fd\u306e\u4f7f\u3044\u3084\u3059\u3055\u3001\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30fb\u30d9\u30fc\u30b9\u306e\u7d71\u5408\u3055\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3068\u3044\u30463\u3064\u306e\u57fa\u672c\u539f\u5247\u304c\u3042\u308a\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u3053\u306e3\u3064\u3059\u3079\u3066\u3092\u6975\u3081\u3066\u53b3\u3057\u3044\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306e\u4e2d\u3067\u6e80\u305f\u3057\u3066\u304f\u308c\u307e\u3057\u305f\u3002\u300d<\/p>\n Idorsia\u793e\u306f\u3001\u6025\u6210\u9577\u4e2d\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u3067\u3001\u7814\u7a76\u3068\u81e8\u5e8a\u958b\u767a\u306e\u521d\u671f\u6bb5\u968e\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002Idorsia\u793e\u306f\u3001\u5275\u696d\u3057\u3066\u304b\u3089\u3059\u3050\u306b\u3001\u65b0\u3057\u3044\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u79fb\u884c\u309212\u304b\u6708\u4ee5\u5185\u306b\u5b9f\u73fe\u3059\u308b\u3068\u3044\u3046\u6311\u6226\u7684\u306a\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u3092\u8a2d\u5b9a\u3057\u307e\u3057\u305f\u3002<\/p>\n Idorsia\u793e\u306f\u3001\u81e8\u5e8a\u958b\u767a\u30fb\u85ac\u4e8b\u30fb\u54c1\u8cea\u696d\u52d9\u306e\u60c5\u5831\u3092\u4e00\u5143\u7ba1\u7406\u3057\u3066\u30c1\u30fc\u30e0\u306b\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u3001<\/p>\n ³Ô¹Ï±¬ÁÏ Development Cloud\u3067\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3057\u3001\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u3068\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3092\u5408\u7406\u5316\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u624b\u4f5c\u696d\u3067\u306e\u91cd\u8907\u3057\u305f\u4f5c\u696d\u304c\u4e0d\u8981\u3068\u306a\u308a\u3001\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u30c1\u30fc\u30e0\u306b\u4e00\u8cab\u6027\u306e\u3042\u308b\u60c5\u5831\u304c\u63d0\u4f9b\u3055\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u6700\u65b0\u304b\u3064\u76f4\u89b3\u7684\u306a\u540c\u4e00\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30fc\u30b9\u3092\u5099\u3048\u3066\u3044\u308b\u305f\u3081\u3001\u30c1\u30fc\u30e0\u306f\u306f\u308b\u304b\u306b\u30b9\u30d4\u30fc\u30c7\u30a3\u306b\u4f5c\u696d\u304c\u53ef\u80fd\u3068\u306a\u308a\u3001\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u306b\u304b\u304b\u308b\u6642\u9593\u3082\u77ed\u7e2e\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n Idorsia\u793e\u306e\u81e8\u5e8a\u958b\u767a\u30fb\u54c1\u8cea\u30b7\u30b9\u30c6\u30e0\u90e8\u9580\u30a2\u30bd\u30b7\u30a8\u30a4\u30c8\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bSimone Mechler\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u3001\u7d44\u7e54\u5168\u4f53\u306e\u30d3\u30b8\u30cd\u30b9\u30d7\u30ed\u30bb\u30b9\u3001\u30b3\u30f3\u30c6\u30f3\u30c4\u3001\u304a\u3088\u3073\u30c7\u30fc\u30bf\u3092\u7ba1\u7406\u3059\u308b\u305f\u3081\u306e\u9069\u5207\u306a\u6280\u8853\u57fa\u76e4\u3092\u63d0\u4f9b\u3057\u3066\u304f\u308c\u3066\u3044\u307e\u3059\u3002\u5f53\u521d\u306e\u76ee\u6a19\u3088\u308a\u306f\u308b\u304b\u306b\u65e9\u304f\u30017\u304b\u6708\u4ee5\u5185\u306b\u7a3c\u50cd\u3092\u958b\u59cb\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u3059\u3079\u3066\u306e\u5730\u57df\u3068\u90e8\u9580\u306b\u304a\u3044\u3066\u3001\u958b\u767a\u4e2d\u306e\u88fd\u54c1\u306b\u5bfe\u3059\u308b\u4e00\u8cab\u3057\u305f\u8996\u70b9\u3092\u5f97\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u904b\u7528\u52b9\u7387\u306e\u5411\u4e0a\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u78ba\u4fdd\u3092\u5b9f\u73fe\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Idorsia\u793e\u3067\u306f\u3001Vault Clinical Suite<\/a><\/strong>\u306eVault eTMF<\/a><\/strong>\u304a\u3088\u3073Vault CTMS<\/a><\/strong>\u3001Vault RIM Suite<\/a><\/strong>\u306eVault Registrations<\/a><\/strong>\u3001Vault Submissions<\/a><\/strong>\u304a\u3088\u3073Vault Submissions Publishing<\/a><\/strong>\u3001\u305d\u3057\u3066Vault Quality Suite<\/a><\/strong>\u306eVault QMS<\/a><\/strong>\u304a\u3088\u3073Vault QualityDocs<\/a><\/strong>\u3068\u3001³Ô¹Ï±¬ÁÏ Development Cloud\u306e\u8907\u6570\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5229\u7528\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306e\u30e8\u30fc\u30ed\u30c3\u30d1R&D\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bRik Van Mol\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cIdorsia\u793e\u3067\u306f\u3001\u81e8\u5e8a\u958b\u767a\u30fb\u85ac\u4e8b\u30fb\u54c1\u8cea\u696d\u52d9\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3057\u3066\u3001\u533b\u85ac\u54c1\u958b\u767a\u3092\u5408\u7406\u5316\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Development Cloud\u306f\u3001Idorsia\u793e\u306e\u3088\u3046\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u304a\u3051\u308b\u3001\u672c\u793e\u30fb\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u30fb\u8af8\u5916\u56fd\u3092\u7db2\u7f85\u3059\u308b\u9023\u643a\u306e\u5b9f\u73fe\u3068\u3001\u8077\u80fd\u3092\u8d8a\u3048\u305f\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u30fb\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5f37\u5316\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u300d<\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2018\u5e747\u670824\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b V…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41592","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41592"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41592"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41592\/revisions"}],"predecessor-version":[{"id":41717,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41592\/revisions\/41717"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067625\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April\u00a030, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"